Genetic inhibition of telomerase results in sensitization and recovery of breast tumor cells

Molecular Cancer Therapeutics

Volumn 8, Issue 5, 2009, Pages 1319-1327

  Poynter, Kennon R ^a   Sachs, Patrick C ^a   Bright, A Taylor ^a   Breed, Meghan S ^a   Nguyen, Binh N ^a   Elmore, Lynne W ^a   Holt, Shawn E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; DOXORUBICIN; PACLITAXEL; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RESISTANCE; CELL AGING; CELL FATE; CELL PROLIFERATION; CHROMOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENSITIZATION; TELOMERE; TUMOR CELL; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; ENZYME ACTIVATION; ENZYME STABILITY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; TELOMERASE; TELOMERE;

EID: 66849138225     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-0849     Document Type: Article

References (30)

1. Henderson IC, Patek AJ. The relationship between prognostic and predictive factors in the management of breast cancer. Breast Cancer Res Treat 1998;52:261-288 (Pubitemid 29056100)
2. Gu J, Spitz MR, Zhao H, et al. Roles of tumor suppressor and telomere maintenance genes in cancer and aging - an epidemiological study. Carcinogenesis 2005;26:1741-1747 (Pubitemid 41487989)
3. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460 (Pubitemid 20178256)
4. Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 1988;85:6622-6626 (Pubitemid 18223496)
5. Kirk KE, Harmon BP, Reichardt IK, Sedat JW, Blackburn EH. Block in anaphase chromosome separation caused by a telomerase template mutation. Science 1997;275:1478-1481 (Pubitemid 27111296)
6. de Lange T. Protection of mammalian telomeres. Oncogene 2002;21:532-540 (Pubitemid 34146253)
7. Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997;17:498-502. (Pubitemid 27518407)
8. Parkinson EK, Minty F. Anticancer therapy targeting telomeres and telomerase: current status. BioDrugs 2007;21:375-385 (Pubitemid 350145446)
9. Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999;5:1164-1170 (Pubitemid 29474421)
10. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 1999;13:2388-2399 (Pubitemid 29453610)
11. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR. The hTERTα splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2000;2:426-432 (Pubitemid 32044788)
12. Elmore LW, Rehder CW, Di X, et al. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem 2002;277:35509-35515 (Pubitemid 35052458)
13. Compton SA, Elmore LW, Haydu K, Jackson-Cook CK, Holt SE. Induction ofnitric oxide synthase-dependent telomere shortening after functional inhibition of Hsp90 in human tumor cells. Mol Cell Biol 2006;26:1452-1462 (Pubitemid 43202570)
14. Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272:263-267
15. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995;92:9363-9367
16. Gan Y, Engelke KJ, Brown CA, Au JL. Telomere amount and length assay. Pharm Res 2001;18:1655-1659 (Pubitemid 34020419)
17. Misawa M, Tauchi T, Sashida G, et al. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int J Oncol 2002;21:1087-1092
18. Nakamura M, Masutomi K, Kyo S, et al. Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy. Hum Gene Ther 2005;16:859-868 (Pubitemid 40982334)
19. Ward RJ, Autexier C. Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment. Mol Pharm 2005;68:779-786 (Pubitemid 41206032)
20. Cerone MA, Londoño-Vallejo JA, Autexier C. Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther 2006;5:1669-1675 (Pubitemid 44323234)
21. der-Sarkissian H, Bacchetti S, Cazes L, Londoño-Vallejo JA. The shortest telomeres drive karyotype evolution in transformed cells. Oncogene 2004;23:1221-1228
22. Zou Y, Sfeir A, Gryaznov SM, Shay JW, Wright WE. Does a sentinel or a subset ofsh ort telomeres determine replicative senescence? Mol Biol Cell 2004;15:3709-3718
23. Delhommeau F, Thierry A, Feneux D, et al. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant. Oncogene 2002;21:8262-8271 (Pubitemid 35477866)
24. Klapper W, Qian W, Schulte C, Parwaresch R. DNA damage transiently increases TRF2 mRNA expression and telomerase activity. Leukemia 2003;17:2007-2015 (Pubitemid 37322131)
25. Sachsinger J, González-Suárez E, Samper E, Heicappell R, Müller M, Blasco MA. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells. Cancer Res 2001;61:5580-5586 (Pubitemid 32694946)
26. Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A 2002;99:389-394 (Pubitemid 34060371)
27. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004;23:2919-2933 (Pubitemid 38638853)
28. Marie-Egyptienne DT, Brault ME, Zhu S, Autexier C. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation. Exp Cell Res 2008;314:668-675
29. Rahman R, Mo L, Cui W. Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growth. Biochem Biophys Res Commun 2006;350:796-802. (Pubitemid 44547916)
30. Cong Y, Shay JW. Actions of human telomerase beyond telomeres. Cell Res 2008;18:725-732